Edwin L. Kaplan to Neoplasm Staging
This is a "connection" page, showing publications Edwin L. Kaplan has written about Neoplasm Staging.
Connection Strength
0.120
-
Response rates in metastatic neuroendocrine tumors receiving peptide receptor radionuclide therapy and implications for future treatment strategies. Surgery. 2021 01; 169(1):162-167.
Score: 0.032
-
A Tale of Two Cancers: Traveling to Treat Pancreatic and Thyroid Cancer. J Am Coll Surg. 2017 Jul; 225(1):125-136.e6.
Score: 0.026
-
The Incidence and Survival of Rare Cancers of the Thyroid, Parathyroid, Adrenal, and Pancreas. Ann Surg Oncol. 2016 Feb; 23(2):424-33.
Score: 0.024
-
Hurthle cell carcinoma: an update on survival over the last 35 years. Surgery. 2013 Dec; 154(6):1263-71; discussion 1271.
Score: 0.020
-
MRI phenotype is associated with response to doxorubicin and cyclophosphamide neoadjuvant chemotherapy in stage III breast cancer. Ann Surg Oncol. 2001 Jul; 8(6):549-59.
Score: 0.009
-
The practice of surgical staging and its impact on adjuvant treatment recommendations in patients with stage I endometrial carcinoma. Gynecol Oncol. 1996 Jun; 61(3):409-15.
Score: 0.006
-
Combined modality therapy for stage III non-small cell lung carcinoma: results of treatment and patterns of failure. Int J Radiat Oncol Biol Phys. 1992; 24(1):17-23.
Score: 0.004